Article
Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings
3 Feb 2020
Abstract excerpt
BACKGROUND: With limited information on germline mutations in biliary tract cancers, this study performed somatic and germline testing for patients at Memorial Sloan Kettering Cancer Center with known biliary tract carcinoma with the aim of determining the frequency and range of pathogenic germline alterations (PGAs). METHODS: Patients with biliary tract carcinoma were consented for somatic tumor and matched...
Topics
Join the communities discussing this publication.